Mogrify
Manufacturing · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
25 Cambridge Science Park, Cambridge, Ca...Phone Number
+44 1223734154Website
www.mogrify.co.ukRevenue
$16.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Mogrify
Mogrify is a biopharmaceutical company focused on transforming the development of ex vivo cell therapies and pioneering the field of in vivo reprogramming therapies.Explore more
Mogrify Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mogrify your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Mogrify, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Mogrify had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Mogrify has new funding data
Earning: See what the market has to say on Mogrify recently announced quarterly report
Check out if Mogrify is spiking on competitors!
Check if Mogrify has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Mogrify
Product Launch: Get notified when Mogrify launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Mogrify
Compare insights from companies similar to Mogrify, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mogrify is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mogrify is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mogrify.
Mogrify financials insights
Gather financial insights about Mogrify, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Angel/Seed
$3.7M
2020
Private Equity
$1.1M
2021
Series A
$33M
2023
Series A
$10M
Mogrify Tech Stack
A closer look at the technologies used by Mogrify
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Funding
Left Company
Executive Move
Mogrify has announced that Louise Modis, Chief Scientific Officer, has left the organization to join Amphista Therapeutics as Chief Scientific Officer.
Left Company
Executive Move
Mogrify News & Media
Beyond Yamanaka: Mogrify demystifies cellular reprogramming - Longevity.Technology
Startup moves into animal studies of cellular reprogramming therapies for vision loss, hearing loss, and diabetes.Mogrify Raises Additional $10M in Series A Funding - FinSMEs
Mogrify, a Cambridge, UK-based biopharmaceutical company advancing in vivo reprogramming therapies, raised additional $10M in Series A fundingMogrify Extends Series A Financing to $46 Million USD | Business Wire
Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, aMogrify Extends Series A Financing to $46 Million USD
CAMBRIDGE, England--(BUSINESS WIRE)--Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing, bringing the total raised to $46 million USD in this round. The funding will support further advancement of Mogrify’s pipeline of in vivo reprogramming therapies through pre-clinical translation, continued platform optimization, and
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Mogrify
Sign Up For FreeTo access detailed company insights
Mogrify is a biopharmaceutical company focused on transforming the development of ex vivo cell therapies and pioneering the field of in vivo reprogramming therapies.... Read More
